Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 8,821-8,832 of 23,847
Drug study icon
CompletedNCT01323569

Abuse Potential of Sativex

This summary needs review. Please check the official study record and contact the research team for details.

In Toronto
AddictionDrugA study involving a medication or substance.From 19 Years to 45 Years
Countries
Canada
Sponsor
Jazz Pharmaceuticals
Condition
Addiction
Behavioral study icon
CompletedNCT04497857

Academic-Community EPINET (AC-EPINET)

This study exists to understand what helps this type of care work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether this type of care can better prevent setbacks and support longer-term stability.

Multiple locations, including Indianapolis
Schizophrenia, Bipolarity, ...BehavioralFrom 16 Years to 35 Years
Countries
United States
Sponsor
Indiana University
Condition
Schizophrenia, Bipolarity, ...
Drug study icon
CompletedNCT00330174

Acamprosate in Alcoholics With Comorbid Anxiety or Depression

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Belmont
Depression, AnxietyDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
Medical University of South Carolina
Condition
Depression, Anxiety
Drug study icon
CompletedNCT00511940

Acamprosate in the Treatment of Binge-Eating disorders

This summary needs review. Please check the official study record and contact the research team for details.

In Mason
Eating disordersDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Lindner Center of HOPE
Condition
Eating disorders
Drug study icon
CompletedNCT00360594

Acamprosate Initiated During Alcohol Detoxification

This summary needs review. Please check the official study record and contact the research team for details.

In Philadelphia
AddictionDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Forest Laboratories
Condition
Addiction
Drug study icon
CompletedNCT00466661

Acamprosate vs. Placebo in Bipolar Alcoholics

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand whether a medication treatment can work better when mental health difficulties overlap with substance use.

In Charleston
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Medical University of South Carolina
Condition
Bipolarity
Device study icon
UnknownNCT06323486

Accelerated Bilateral Sequential Theta Burst Stimulation in Older Adults With Treatment-resistant Depression

This study is looking at care and outcomes for people with depression, Treatment-Resistant. Some participants may receive absTBS-sham treatment sequence arm instead of the study treatment, and direct benefit is not guaranteed.

In Toronto
DepressionDeviceA study involving a tool, app, wearable, test, or medical device.Over 50 Years
Countries
Canada
Sponsor
Ontario Shores Centre for Mental Health Sciences
Condition
Depression
Device study icon
Enrolling By InvitationNCT07155096

Accelerated DMN-Targeted cTBS to Modulate DMN Connectivity

This study is looking at whether a digital support tool can help people with Schizophrenia. Participants take part in a digital support tool and complete follow-up assessments.

In Nashville
SchizophreniaDeviceFrom 18 Years to 65 Years
Countries
United States
Sponsor
Vanderbilt University Medical Center
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.